Q4 2024 EPS Estimates for Celsius Holdings, Inc. Decreased by Analyst (NASDAQ:CELH)

Celsius Holdings, Inc. (NASDAQ:CELH - Free Report) - Research analysts at Roth Capital cut their Q4 2024 EPS estimates for Celsius in a research note issued on Monday, April 29th. Roth Capital analyst S. Mcgowan now anticipates that the company will post earnings of $0.25 per share for the quarter, down from their previous forecast of $0.26. The consensus estimate for Celsius' current full-year earnings is $1.09 per share.

Celsius (NASDAQ:CELH - Get Free Report) last posted its earnings results on Thursday, February 29th. The company reported $0.17 earnings per share for the quarter, topping analysts' consensus estimates of $0.16 by $0.01. The firm had revenue of $347.44 million for the quarter, compared to analysts' expectations of $326.77 million. Celsius had a net margin of 17.21% and a return on equity of 131.58%. The company's revenue was up 95.2% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.01 earnings per share.

CELH has been the topic of a number of other reports. Maxim Group boosted their price objective on Celsius from $100.00 to $110.00 and gave the company a "buy" rating in a research note on Monday, April 1st. Wedbush increased their target price on Celsius from $75.00 to $90.00 and gave the stock an "outperform" rating in a report on Monday, March 4th. Roth Mkm upped their price objective on shares of Celsius from $90.00 to $105.00 and gave the stock a "buy" rating in a report on Thursday, March 14th. UBS Group lifted their price objective on shares of Celsius from $73.00 to $99.00 and gave the company a "buy" rating in a report on Friday, March 1st. Finally, Stifel Europe upped their target price on shares of Celsius from $90.00 to $95.00 and gave the stock a "buy" rating in a report on Monday, March 18th. Two analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $85.10.

Celsius Stock Down 3.3 %

Shares of NASDAQ CELH traded down $2.46 during midday trading on Tuesday, reaching $71.27. 2,743,697 shares of the company were exchanged, compared to its average volume of 4,651,434. Celsius has a one year low of $32.06 and a one year high of $99.62. The stock has a market cap of $16.46 billion, a P/E ratio of 92.16, a PEG ratio of 2.13 and a beta of 1.86. The stock's 50-day moving average price is $80.12 and its 200-day moving average price is $65.21.

Insider Buying and Selling

In related news, Director Caroline S. Levy sold 20,000 shares of the business's stock in a transaction dated Wednesday, March 13th. The shares were sold at an average price of $94.77, for a total value of $1,895,400.00. Following the transaction, the director now directly owns 37,891 shares of the company's stock, valued at approximately $3,590,930.07. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. In other Celsius news, major shareholder Dean Desantis sold 100,000 shares of the business's stock in a transaction on Wednesday, March 13th. The stock was sold at an average price of $95.75, for a total value of $9,575,000.00. Following the sale, the insider now directly owns 219,257 shares in the company, valued at $20,993,857.75. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Caroline S. Levy sold 20,000 shares of the stock in a transaction on Wednesday, March 13th. The stock was sold at an average price of $94.77, for a total value of $1,895,400.00. Following the transaction, the director now owns 37,891 shares of the company's stock, valued at approximately $3,590,930.07. The disclosure for this sale can be found here. Over the last three months, insiders have sold 523,980 shares of company stock worth $37,925,992. 2.20% of the stock is owned by company insiders.

Institutional Investors Weigh In On Celsius

Institutional investors have recently added to or reduced their stakes in the business. Cary Street Partners Investment Advisory LLC boosted its holdings in Celsius by 1,350.0% in the 3rd quarter. Cary Street Partners Investment Advisory LLC now owns 145 shares of the company's stock worth $25,000 after buying an additional 135 shares during the period. Contravisory Investment Management Inc. purchased a new position in shares of Celsius in the fourth quarter valued at $25,000. Transcendent Capital Group LLC bought a new stake in shares of Celsius during the 4th quarter valued at $25,000. Tidemark LLC purchased a new stake in Celsius during the 4th quarter worth about $29,000. Finally, Heritage Wealth Advisors boosted its stake in Celsius by 200.0% in the 4th quarter. Heritage Wealth Advisors now owns 552 shares of the company's stock worth $30,000 after purchasing an additional 368 shares during the period. 60.95% of the stock is owned by hedge funds and other institutional investors.

About Celsius

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.